Search Results

Your search for SYED ALI ABUTALIB, MD, and ALAN F. LIST, MD matches 2 pages

Showing 1 - 2

By SYED ALI ABUTALIB, MD, and ALAN F. LIST, MD / February 10, 2020

Selected ASH Abstracts on Myelodysplastic Syndromes

To complement The ASCO Post’s continued comprehensive coverage of the 2019 American Society of Hematology (ASH) Annual Meeting & Exposition, here are several abstracts selected from the meeting proceedings focusing on novel therapies for myelodysplastic syndromes (MDS), including the...

myelodysplastic syndromes

By Syed Ali Abutalib, MD, and Alan F. List, MD / February 10, 2019 / 2018 ASH Annual Meeting & Exposition

Novel Treatments of Myelodysplastic Syndromes

AS PART of The ASCO Post’s continued coverage of the 2018 American Society of Hematology (ASH) Annual Meeting & Exposition, here is an update on seven different studies on new therapeutics in myelodysplastic syndromes (MDS). Among the treatments highlighted here are the erythroid maturation...

Apr

Today In Oncology

Search Results

Your search for SYED ALI ABUTALIB, MD, and ALAN F. LIST, MD matches 2 pages

Selected ASH Abstracts on Myelodysplastic Syndromes

Novel Treatments of Myelodysplastic Syndromes

FDA Approves Lu-177 Dotatate for Pediatric Patients With GEP-NETs

AI Model May Help Predict Treatment Responses Select Most Effective Cancer Therapies in Patients With Cancer

In-Hospital Mortality Among Patients With COVID-19 Infection, With or Without Cancer

Imaging Drug to Assist in Detection of Cancerous Tissue Following Lumpectomy Approved

Potential Protective Effects of Aspirin Against Colorectal Cancer